Highbridge Capital Management Llc - Sep 30, 2025 SCHEDULE 13G/A Report for Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI)

Filing Manager: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Reporting Manager: HIGHBRIDGE CAPITAL MANAGEMENT, LLC
Security: Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol: KPTI
Shares outstanding: 13.3M shares
Disclosed Ownership: 650K shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 10:45 AM
Date of event: Sep 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
HIGHBRIDGE CAPITAL MANAGEMENT, LLC	4.9%	650K	650K	0	/s/ Kirk Rule	Kirk Rule, Executive Director